Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -48,740 | -35,090 | -26,791 | -179,053 | -156,797 |
| Depreciation Amortization | 232 | 155 | 78 | 318 | 240 |
| Accounts receivable | 68 | -741 | -307 | 177 | -487 |
| Other Working Capital | -2,247 | -1,001 | 4,345 | 2,306 | 11,432 |
| Other Operating Activity | -6,531 | -4,203 | 4,969 | 21,246 | 17,469 |
| Operating Cash Flow | $-57,218 | $-40,880 | $-17,706 | $-155,006 | $-128,143 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -20 | -20 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-20 | $-20 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 32,687 | 32,219 | 26,743 | 27,540 | 25,165 |
| Other Financing Activity | -303 | -289 | -117 | -1,018 | -766 |
| Financing Cash Flow | $32,384 | $31,930 | $26,626 | $26,522 | $24,399 |
| Beginning Cash Position | 65,221 | 65,221 | 65,221 | 193,725 | 193,725 |
| End Cash Position | 40,387 | 56,271 | 74,141 | 65,221 | 89,961 |
| Net Cash Flow | $-24,834 | $-8,950 | $8,920 | $-128,504 | $-103,764 |
| Free Cash Flow | |||||
| Operating Cash Flow | -57,218 | -40,880 | -17,706 | -155,006 | -128,143 |
| Capital Expenditure | N/A | N/A | N/A | -20 | -20 |
| Free Cash Flow | -57,218 | -40,880 | -17,706 | -155,026 | -128,163 |